Erratum: Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis (EMBO Journal (2014) 33 (468481) DOI: 10.1002/embj.201386082);Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis

EMBO Journal

Volumn 33, Issue 5, 2014, Pages 468-481

  Lau, Allison N ^a,b,c   Curtis, Stephen J ^a,b,c   Fillmore, Christine M ^a,b,c   Rowbotham, Samuel P ^a,b,c   Mohseni, Morvarid ^a,b,d   Wagner, Darcy E ^e   Beede, Alexander M ^a,b,c   Montoro, Daniel T ^a,b,c   Sinkevicius, Kerstin W ^a,b,c   Walton, Zandra E ^f,g,h   Barrios, Juliana ^a,b,c   Weiss, Daniel J ^e   Camargo, Fernando D ^a,b,d   Wong, Kwok Kin ^f,g,h   Kim, Carla F ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Harvard University   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h DANA FARBER HARVARD CANCER CENTER   (United States)

Author keywords

CD24; lung cancer; metastasis; Taz; tumor propagating cells

Indexed keywords

ARTICLE; CANCER PROGNOSIS; CELL MIGRATION; CELL TRANSPLANTATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG TUMOR; METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH; TUMOR PROPAGATING CELL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG; LUNG NEOPLASMS; MICE; NEOPLASM METASTASIS; PHOSPHOPROTEINS; TRANSCRIPTION FACTORS;

EID: 84898640056     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.15252/embj.201488991     Document Type: Erratum

References (50)

1. Adhikari AS, Agarwal N, Iwakuma T, (2011) Metastatic potential of tumor-initiating cells in solid tumors. Front Biosci 16: 1927-1938
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988 (Pubitemid 36418143)
3. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabro E, Pastorino U, Sozzi G, (2009) Highly tumorigenic lung cancer CD133 + cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 106: 16281-16286
4. Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci F, Jacquemier J, Xerri L, Dontu G, Stassi G, Xiao Y, Barsky SH, Birnbaum D, Viens P, Wicha MS, (2010) Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 16: 45-55
5. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, Hur MH, Diebel ME, Monville F, Dutcher J, Brown M, Viens P, Xerri L, Bertucci F, Stassi G, Dontu G, Birnbaum D, Wicha MS, (2009) Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69: 1302-1313
6. Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, Wang CY, Hung SC, Chang YL, Tsai ML, Lee YY, Ku HH, Chiou SH, (2008) Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE 3: e2637
7. Chitale D, Gong Y, Taylor BS, Broderick S, Brennan C, Somwar R, Golas B, Wang L, Motoi N, Szoke J, Reinersman JM, Major J, Sander C, Seshan VE, Zakowski MF, Rusch V, Pao W, Gerald W, Ladanyi M, (2009) An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. Oncogene 31: 2773-2783
8. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, Daidone MG, Dupont S, Basso G, Bicciato S, Piccolo S, (2011) The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells. Cell 147: 759-772
9. Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA, Allan AL, (2009) High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med 13: 2236-2252
10. Curtis SJ, Sinkevicius KW, Li D, Lau AN, Roach RR, Zamponi R, Woolfenden AE, Kirsch DG, Wong KK, Kim CF, (2010) Primary tumor genotype is an important determinant in identification of lung cancer propagating cells. Cell Stem Cell 7: 127-133
11. Damelin M, Geles KG, Follettie MT, Yuan P, Baxter M, Golas J, DiJoseph JF, Karnoub M, Huang S, Diesl V, Behrens C, Choe SE, Rios C, Gruzas J, Sridharan L, Dougher M, Kunz A, Hamann PR, Evans D, Armellino D, et al, (2011) Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells. Cancer Res 71: 4236-4246
12. Dieter SM, Ball CR, Hoffman CM, Nowrouzi A, Herbst F, Zavidij O, Abel U, Arens A, Weichert W, Brand K, Koch M, Weitz J, Schmidt M, von Kalle C, Glimm H, (2011) Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell 9: 357-365
13. Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, Shedden K, Taylor JM, Enkemann SA, Tsao M, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giodano TJ, Misek DE, Chang AC, Zhu CQ, Strumpf D, Hanash S, Shepherd FA, Ding K, Seymour L, Naoki K, Pennell N, Weir B, et al, (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14: 822-827
14. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R, (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514 (Pubitemid 351267301)
15. Gunawardane RN, Sgroi DC, Wrobel CN, Koh E, Daley GQ, Brugge JS, (2005) Novel role for PDEF in epithelial cell migration and invasion. Cancer Res 65: 11572-11580 (Pubitemid 41821716)
16. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C, (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323 (Pubitemid 47355323)
17. Ignatius MS, Chen E, Elpeck NM, Fuller AZ, Tenente IM, Clagg R, Liu S, Blackburn JS, Linardic CM, Rosenberg AE, Nielsen PG, Mempel TR, Langenau DM, (2012) In Vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell movements in embryonal rhabdomyosarcoma. Cancer Cell 21: 680-693
18. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP, (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264
19. Jackson EL, Olive KP, Tuveson DA, Bronson R, Crowley D, Brown M, Jacks T, (2005) The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res 65: 10280-10288 (Pubitemid 41743720)
20. Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, Jacks T, Tuveson DA, (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15: 3243-3248 (Pubitemid 34008190)
21. Korkaya H, Paulso A, Iovino F, Wicha MS, (2008) HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 27: 6120-6130
22. Kristiansen G, Schluns K, Yongwei Y, Denkert C, Dietel M, Petersen I, (2003) CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Br J Cancer 88: 231-236 (Pubitemid 36255841)
23. Lee HJ, Choe G, Jheon S, Sung SW, Lee CT, Chung JH, (2010) CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification. J Thorac Oncol 5: 649-657
24. Lee TK, Castilho A, Cheung VC, Tang KH, Ma S, Ng IO, (2011) CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell 9: 50-63
25. Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE, (2008) Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS ONE 3: e3077
26. Liu W, Monahan KB, Pfefferle AD, Shimamura T, Sorrentiono J, Chan K, Roadcap DW, Ollila DW, Thomas NE, Castrillon DH, Miller CM, Perour CM, Wong KK, Bear JE, Sharpless NE, (2012) LKB1/STK11 inactivation leads to expansion of a pro-metastatic tumor sub-population in melanoma. Cancer Cell 21: 751-764
27. Malanchi I, Santamaria-Martínez A, Susanto E, Peng H, Lehr HA, Delaloye JF, Huelsken J, (2011) Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481: 85-89
28. Meylan E, Dooley AL, Feldser DM, Shen L, Turk E, Ouyang C, Jacks T, (2009) Requirement for NF-KappaB signaling in a mouse model of lung adenocarcinoma. Nature 462: 104-107
29. Mitani A, Nagase T, Fukuchi K, Aburatani H, Makita R, Kurihara H, (2009) Transcriptional coactivator with PDZ-binding motif is essential for normal alveolarization in mice. Am J Respir Crit Care Med 180: 326-338
30. Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG, Ladanyi M, Gerald WL, Massague J, (2009) WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 138: 51-62
31. Overdevest JB, Thomas S, Kristiansen G, Hansel DE, Smith SC, Theodorescu D, (2011) CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization. Cancer Res 71: 3802-3811
32. Pan D, (2010) The hippo signaling pathway in development and cancer. Dev Cell 19: 491-505
33. Pang R, Law WL, Chu AC, Poon JT, Lam CS, Chow AK, Ng L, Cheung LW, Lan XR, Lan HY, Tan VP, Yau TC, Poon RT, Wong BC, (2010) A subpopulation of CD26 + cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 6: 603-615
34. Patsialou A, Wang Y, Lin J, Whitney K, Goswami S, Kenny PA, Condeelis JS, (2012) Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients. Breast Cancer Res 14: R129
35. Pisters KM, Ginsberg RJ, Giroux DJ, Putnam JB, Kris MG, Johnson DH, Roberts JR, Mault J, Crowley JJ, Bunn PA, (2000) Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team. J Thorac Cardiovasc Surg 119: 429-439 (Pubitemid 30146520)
36. Schadt EE, Li C, Ellis B, Wong WH, (2001) Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J Cell Biochem Suppl 37: 120-125
37. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, Kreger BT, Vasioukhin V, Avruch J, Brummelkamp TR, Camargo FD, (2011) Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144: 782-795
38. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, et al, (2007) Molecular definition of breast tumor heterogeneity. Cancer Cell 11: 259-273 (Pubitemid 46349843)
39. Siegel R, Naishadham D, Jemal A, (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30
40. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: 3
41. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP, (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550 (Pubitemid 41528093)
42. Wang Y, Dong Q, Zhang Q, Li Z, Wang E, Qiu X, (2010) Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci 101: 1279-1285
43. Winslow MM, Dayton TL, Verhaak RG, Kim-Kiselak C, Snyder EL, Feldser DM, Hubbard DD, DuPage MJ, Whittaker CA, Hoersch S, Yoon S, Crowley D, Bronson RT, Chiang DY, Meyerson M, Jacks T, (2011) Suppression of lung adenocarcinoma progression by Nk2-1. Nature 473: 101-104
44. Wu Y, Siadaty MS, Berens ME, Hampton GM, Theodorescu D, (2008) Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration. Oncogene 27: 6679-6689
45. Xie M, Zhang L, He CS, Hou JH, Lin SX, Hu ZH, Xu F, Zhao HY, (2012) Prognostic significance of TAZ expression in resected non-small cell lung cancer. J Thorac Oncol 7: 799-807
46. Xu Y, Stamenkovic I, Yu Q, (2010) CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma. Cancer Res 70: 2455-2464
47. Xue W, Meylan E, Oliver TG, Feldser DM, Winslow MM, Bronson R, Jacks T, (2011) Response and resistance to NF-kB inhibitors in mouse models of lung adenocarcinoma. Cancer Discov 1: 236-247
48. Yao X, Labelle M, Lamb CR, Dugan JM, Williamson CA, Spencer DR, Christ KR, Keating RO, Lee WD, Paradis GA, Begum S, Hynes RO, Wittrup KD, (2013) Determination of 35 cell surface antigen levels in malignant pleural effusions identifies CD24 as a marker of disseminated tumor cells. Int J Cancer 133: 2925-2933
49. Zheng Y, de la Cruz CC, Sayles LC, Alleyne-Chin C, Vaka D, Knaak TD, Bigos M, Xu Y, Hoang CD, Shrager JB, Fehling HJ, French D, Forrest W, Jiang Z, Carano RA, Barck KH, Jackson EL, Sweet-Cordero EA, (2013) A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch 3 for self-renewal. Cancer Cell 24: 59-74
50. Zhou Z, Hao Y, Liu N, Raptis L, Tsao MS, Yang X, (2011) TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 30: 2181-2186